You are here: Industry Insights > mRNA vaccine

News List

Pharmaceutical Business in China and Worldwide (August)(2023) PharmaSources
October 01, 2023
On August 7, Yabao Pharmaceutical announced that it had signed a technology transfer agreement with Shanxi University.
Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"? PharmaSources/Yefenghong
May 23, 2022
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
Designing the Messenger: Story of the mRNA Vaccine Neeta Ratanghayra
November 05, 2020
In early January this year, Chinese authorities shared the genetic sequence of SARS-CoV-2, the novel coronavirus.
Inactivated Virus Vaccines vs. mRNA Vaccines: Differences between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines PharmaSources/Xiaoyaowan
November 13, 2020
The cumulative number of confirmed cases of COVID-19 has exceeded 11.30 million worldwide by July 5. The vaccine development has been in full swing in each country since the occurrence of the virus.
Recbio Provides Updates on First Lyophilized mRNA Vaccine and Pre-clinical Data Showing Long-term stability and Strong immunogenicity against SARS-CoV-2 prnasia
February 15, 2022
Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data...
Celartics Biopharma announces a new generation mRNA vaccine against COVID-19 FirstWordPharma
February 14, 2022
Celartics Biopharma today announced that they have achieved major milestones and encouraging results in developing a new generation of mRNA vaccine, CA-R03, designed to prevent infection from SARS-COV-2 virus.
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN AmericanPharmaceuticalReview
February 09, 2022
Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.
Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement prnasia
October 13, 2021
Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company...
Vaccine Approval Important Step Forward Against Pandemic, Reminder of What's at Stake in Drug Pricing Debate firstwordpharma
August 24, 2021
Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl made the following statement after the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine.
New Capacity Helps Eliminate Bottleneck for COVID-19 Vaccines b3cnewswire
August 17, 2021
Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production.

Previous page 1 2 3 4 5 Next page